Company: APTV
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001521332-25-000051
Chunk: 58

Company: Aptiv PLC
Filing Date: 2025-10-30
Form: 10-Q
Item: Item 1
Chunk 58
---
IP. Any off-cycle grants made to new hires or other employees are valued at their grant date fair value based on the closing price of the Company’s ordinary shares on the date of such grant.The details of shares issued for vested annual executive grants are as follows:Time-Based AwardsPerformance-Based AwardsVesting DateOrdinary Shares Issued Upon VestingFair Value of Shares at IssuanceOrdinary Shares Withheld to Cover Withholding TaxesOrdinary Shares Issued Upon VestingFair Value of Shares at IssuanceOrdinary Shares Withheld to Cover Withholding Taxes(dollars in millions)Q1 2025554,363 $36 224,317 138,010 $9 58,518 Q1 2024461,052 $36 188,897 151,245 $12 65,910 A summary of RSU activity, including award grants, vesting and forfeitures is provided below:RSUsWeighted Average Grant Date Fair Value (in thousands)Nonvested, January 1, 20252,770 $92.98 Granted2,283 $69.39 Vested(635)$96.62 Forfeited(305)$82.70 Nonvested, September 30, 20254,113 $80.09 Aptiv recognized share-based compensation expense related to these RSUs of $40 million ($35 million, net of tax) and $32 million ($27 million, net of tax) based on the Company’s best estimate of ultimate performance against the respective targets during the three months ended September 30, 2025 and 2024, respectively. Aptiv recognized share-based compensation expense of $107 million ($93 million, net of tax) and $84 million ($71 million, net of tax) based on the Company’s best estimate of ultimate performance against the respective targets during the nine months ended September 30, 2025 and 2024, respectively. Aptiv will continue to recognize compensation expense, based on the grant date fair value of the awards applied to the Company’s best estimate of ultimate performance against the respective targets, over the requisite vesting periods of the awards. Based on the grant date fair value of the awards and the Company’s best estimate of ultimate performance against the respective targets as of September 30, 2025, unrecognized compensation expense on a pre-tax basis of approximately $223 million is anticipated to be recognized over a weighted average period of approximately two